BROOKS LABORATORIES
|
BROOKS LABORATORIES Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Profit Before Tax | ₹-20 Cr | ₹-38 Cr | ₹-24 Cr | ₹-8.99 Cr |
Adjustment | ₹23 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr |
Changes In working Capital | ₹-13 Cr | ₹11 Cr | ₹-24 Cr | ₹7.37 Cr |
Cash Flow after changes in Working Capital | ₹-9.88 Cr | ₹-14 Cr | ₹-37 Cr | ₹8.66 Cr |
Cash Flow from Operating Activities | ₹-9.68 Cr | ₹-14 Cr | ₹-37 Cr | ₹4.46 Cr |
Cash Flow from Investing Activities | ₹0.18 Cr | ₹0.49 Cr | ₹-25 Cr | ₹-5.13 Cr |
Cash Flow from Financing Activities | ₹9.60 Cr | ₹11 Cr | ₹64 Cr | ₹1.16 Cr |
Net Cash Inflow / Outflow | ₹0.10 Cr | ₹-2.58 Cr | ₹1.72 Cr | ₹0.49 Cr |
Opening Cash & Cash Equivalents | ₹0.02 Cr | ₹2.61 Cr | ₹0.88 Cr | ₹0.40 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - |
Closing Cash & Cash Equivalent | ₹0.13 Cr | ₹0.02 Cr | ₹2.61 Cr | ₹0.88 Cr |
Compare Cashflow Statement of peers of BROOKS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BROOKS LABORATORIES | ₹462.0 Cr | 3.7% | 17.7% | 92.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
BROOKS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BROOKS LABORATORIES | 3.7% |
17.7% |
92.7% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses